Opioid Peptides Relaxed Blood Vessels by Blocking Nerve Signals
Both enkephalins and dynorphin relaxed rabbit arteries by blocking nerve-driven contraction, with maximum effects varying between blood vessel types.
Quick Facts
What This Study Found
In rabbit ear and saphenous (leg) arteries, both delta-selective opioid agonists (leu-enkephalin and met-enkephalin) and kappa-selective agonists (dynorphin-(1-13) and ethylketocyclazocine) inhibited nerve-stimulation-evoked contractions.
Delta agonists showed a vessel-specific difference: their maximum inhibitory effect was significantly less in the saphenous artery than in the ear artery. Kappa agonists worked similarly in both vessels.
Yohimbine (an alpha-2 adrenergic blocker) did not enhance opioid inhibitory effects at any stimulation frequency in either vessel. This disproved the hypothesis that opioid receptors work by boosting alpha-2 receptor inhibition of noradrenaline release.
Key Numbers
How They Did This
In vitro ring segments of rabbit ear and saphenous arteries were transmurally stimulated electrically. Opioid peptides were applied and contractile responses measured. Two stimulation patterns: short (8 Hz, 1 second) and long (2 Hz, 25 seconds). Yohimbine tested alpha-2 receptor interaction.
Why This Research Matters
This study showed opioid peptides directly relax blood vessels by blocking nerve-driven contractions. The vessel-specific differences for delta agonists suggest different parts of the circulatory system respond differently to the same opioid signals. This matters for understanding why opioids cause blood pressure changes.
The Bigger Picture
Opioid receptors on blood vessel nerves represent a local regulatory mechanism. This could explain regional blood flow changes during pain and contribute to blood pressure effects of opioid drugs.
What This Study Doesn't Tell Us
In vitro study with isolated rabbit blood vessels. Results may not apply to intact animals or humans. Only two vessel types were tested. The physiological concentrations of endogenous opioid peptides at blood vessel nerve terminals are unknown.
Questions This Raises
- ?Do vascular opioid receptors contribute to opioid-induced hypotension?
- ?Can peripheral opioid receptors be targeted for blood flow disorders?
Trust & Context
- Key Stat:
- Pre-junctional inhibition Opioids block nerve signals at the blood vessel wall to reduce contraction
- Evidence Grade:
- Preliminary in-vitro study comparing two vessel types with receptor-selective agonists.
- Study Age:
- Published in 1988 — established opioid receptor function in blood vessel innervation.
- Original Title:
- Comparison of the pre-junctional effect of opioids in two blood vessels of the rabbit.
- Published In:
- European journal of pharmacology, 158(1-2), 21-8 (1988)
- Authors:
- Gan, E A, Duckles, S P
- Database ID:
- RPEP-00073
Evidence Hierarchy
Frequently Asked Questions
What does pre-junctional mean?
Pre-junctional refers to nerve terminals before the synapse. Opioid receptors here block the release of noradrenaline from nerve endings, preventing the vessel from contracting.
Why do different vessels respond differently?
Different blood vessels have different densities and types of opioid receptors. Ear arteries and leg arteries have distinct receptor profiles, reflecting their different regulatory needs.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00073APA
Gan, E A; Duckles, S P. (1988). Comparison of the pre-junctional effect of opioids in two blood vessels of the rabbit.. European journal of pharmacology, 158(1-2), 21-8.
MLA
Gan, E A, et al. "Comparison of the pre-junctional effect of opioids in two blood vessels of the rabbit.." European journal of pharmacology, 1988.
RethinkPeptides
RethinkPeptides Research Database. "Comparison of the pre-junctional effect of opioids in two bl..." RPEP-00073. Retrieved from https://rethinkpeptides.com/research/gan-1988-comparison-of-the-prejunctional
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.